BNGO
BNGO
NASDAQ · Life Sciences Tools & Services

Bionano Genomics Inc

$1.73
+0.05 (+2.98%)
As of Sep 29, 10:26 PM ET ·
Financial Highlights (FY 2026)
Revenue
59.50M
Net Income
-55,087,020
Gross Margin
46.2%
Profit Margin
-92.6%
Rev Growth
+0.8%
D/E Ratio
0.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 46.2% 46.2% 30.2% 30.2%
Operating Margin -116.9% -105.3% 15.6% 17.4%
Profit Margin -92.6% -88.0% 13.5% 12.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 59.50M 59.00M 4.56M 4.59M
Gross Profit 27.52M 27.29M 1.38M 1.39M
Operating Income -69,580,763 -62,101,037 710.4K 800.1K
Net Income -55,087,020 -49,165,329 617.9K 580.5K
Gross Margin 46.2% 46.2% 30.2% 30.2%
Operating Margin -116.9% -105.3% 15.6% 17.4%
Profit Margin -92.6% -88.0% 13.5% 12.6%
Rev Growth +0.8% +0.8% +4.6% -9.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 752.1K 752.1K 5.02M 4.32M
Total Equity 8.96M 8.96M 5.58M 6.22M
D/E Ratio 0.08 0.08 0.90 0.70
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -58,308,650 -54,931,790 871.5K 857.6K
Free Cash Flow — — 406.9K 381.9K